1. Trang chủ
  2. » Luận Văn - Báo Cáo

Báo cáo khoa học: Escherichia coli cyclophilin B binds a highly distorted form of trans-prolyl peptide isomer doc

10 250 0
Tài liệu đã được kiểm tra trùng lặp

Đang tải... (xem toàn văn)

THÔNG TIN TÀI LIỆU

Thông tin cơ bản

Định dạng
Số trang 10
Dung lượng 588,97 KB

Các công cụ chuyển đổi và chỉnh sửa cho tài liệu này

Nội dung

To date, only short peptides with a cis-form proline have been observed in complexes of human and Escherichia coli proteins of cyclophilin A, which is present in cytoplasm.. coli CyPA an

Trang 1

Escherichia coli cyclophilin B binds a highly distorted form

Michiko Konno1, Yumi Sano1, Kayoko Okudaira1, Yoko Kawaguchi1, Yoko Yamagishi-Ohmori1,

Shinya Fushinobu2and Hiroshi Matsuzawa2,*

1

Department of Chemistry, Ochanomizu University, Otsuka, Bunkyo-ku, Tokyo, Japan;2Department of Biotechnology,

The University of Tokyo, Yayoi, Bunkyo-ku, Tokyo, Japan

Cyclophilins facilitate the peptidyl-prolyl isomerization of

a trans-isomer to a cis-isomer in the refolding process of

unfolded proteins to recover the natural folding state with

cis-proline conformation To date, only short peptides with a

cis-form proline have been observed in complexes of human

and Escherichia coli proteins of cyclophilin A, which is

present in cytoplasm The crystal structures analyzed in this

study show two complexes in which peptides having a

trans-form proline, i.e succinyl-Ala-trans-Pro-Ala-p-nitroanilide

and acetyl-Ala-Ala-trans-Pro-Ala-amidomethylcoumarin,

are bound on a K163T mutant of Escherichia coli

cyclo-philin B, the preprotein of which has a signal sequence

Comparison with cis-form peptides bound to cyclophilin A

reveals that in any case the proline ring is inserted into the

hydrophobic pocket and a hydrogen bond between CO of

Pro and Ng2of Arg is formed to fix the peptide On the other

hand, in the cis-isomer, the formation of two hydrogen bonds of NH and CO of Ala preceding Pro with the protein fixes the peptide, whereas in the trans-isomer formation of a hydrogen bond between CO preceding Ala-Pro and His47

Ne2via a mediating water molecule allows the large distor-tion in the orientadistor-tion of Ala of Ala-Pro Although loss of double bond character of the amide bond of Ala-Pro is essential to the isomerization pathway occurring by rotating around its bond, these peptides have forms impossible to undergo proton transfer from the guanidyl group of Arg to the prolyl N atom, which induces loss of double bond character

Keywords: cyclophilin; isozyme; peptidyl-prolyl cis-trans isomerase; peptide binding; refolding

Cyclophilins (CyPs) exist abundantly and ubiquitously in a

broad range of organisms from Escherichia coli to humans

[1–3] Two cyclophilins, E coli CyPA and E coli CyPB,

have been identified [4,5], and at least five cyclophilins in

mammals (human CyPA–D, CyP40) [3] have been

identi-fied CyPB homologs have a membrane-binding signal

sequence in the amino-terminal, whereas CyPA homologs

are present in the cytoplasm [1–5] It has been reported that

E coli CyPB exhibits almost equal activity of

peptidyl-prolyl isomerization from cis- to trans-form of short

peptides to E coli CyPA [5] Because cis-proline

conforma-tion in the polypeptide spontaneously converts to

trans-conformation, acceleration of the isomerization of the

cis-isomer to the trans-isomer is not thought to be the

function of the CyPA and CyPB proteins in these cells On

the other hand, CyPs facilitate the step of the isomerization

in which a trans-isomer is converted to a cis-isomer in the process of the refolding of unfolded proteins Although the natural roles of CyPs are still poorly understood, they may

be related to the fixing of distorted trans-isomers at the intermediate step of converting the trans- to the cis-isomer

of proteins It has been reported that in the N-terminal domain of the HIV-1 capsid protein, a loop containing Gly-trans-Pro binds to the human CyPA; this occurs at a position where the Gly residue assumes //w angles in the regions disallowed for residues with side chains [6] Because the distortion of the loop of the capsid protein is concen-trated in the torsional angles of the Gly residue, but as most proteins with a cis-proline, the refolding process of which is accelerated by CyPs, have no flexible Gly residue at the position immediately preceding Pro [7–11], this binding conformation of the capsid protein is not sufficient to serve

as a model of the intermediate formed during isomerization

of the trans-isomer to the cis-isomer To date, the binding structures of peptides in the cis-proline form have been reported for human CyPA [12–15] and E coli CyPA [16], but the peptides forming the distorted trans-conformation have not yet been identified

Based on NMR measurements, Eisenmesser et al [17] proposed a possible mechanism by which the C-terminal peptide segment containing a Pro residue of a tetrapeptide rotates around the Phe-Pro peptide bond Their results indicated that the cis-form in the initial state is inserted into a hydrophobic pocket of human CyPA, whereas the trans-form in the final state is released from the pocket The

Correspondence to M Konno, Department of Chemistry,

Ochanom-izu University, 2-1-1 Otsuka, Bunkyo-ku, Tokyo 112–8610, Japan.

Fax: +81 359785717, Tel.: +81 359785718,

E-mail: konno@cc.ocha.ac.jp

Abbreviations: CyP, cyclophilin; Suc, succinyl; pNA, p-nitroanilide;

Ac, N-acetyl; AMC, amidomethylcoumarin; PPIase, peptidyl-prolyl

cis-trans isomerase.

*Present address: Department of Bioscience and Biotechnology,

Aomori University, 2-3-1 Kohbata, Aomori, 030-0943, Japan.

(Received 23 March 2004, revised 1 August 2004,

accepted 4 August 2004)

Trang 2

trans-form, the proline of which is bound to the pocket, is

only the loop of the capsid protein It has been reported that

E coliCyPA accelerates the conversion of trans- to cis-form

on peptide bonds of not only Ser54-Pro55 but also

Tyr38-Pro39 in the final refolding process of the unfolded RNase

T1, whereas human CyPA accelerates only the conversion

on the Ser54-Pro55 peptide bond [8] The fact that E coli

CyP is bound to structurally diverse substrates, and the

notion that CyPA and CyPB should affect different target

proteins, led us to consider whether E coli CyPB might

bind to peptides of the distorted trans-isomer E coli CyPB

[4,5] consists of 190 amino acids and has a signal sequence of

24 residues at the N-terminal end CyPB molecules are

processed and forms of CyPB without the signal peptide are

present in the periplasm of E coli cells (here, residues

number 25–190 are defined as 1–166)

Analysis of a complex in which a protein is bound to a

peptide containing a Pro residue of trans-form in the initial

state of the isomerization reaction from a trans- to

cis-isomer will be needed As the cis-isomerization of the trans- to

cis-isomer of the short peptides proceeds very slowly or does

not occur at all in CyPB molecules, we used short peptides

in order to obtain the complexes with the distorted

trans-isomer We could obtain no crystals of E coli CyPB having

suitable size for X-ray analysis Thus, we designed a K163T

mutant protein of E coli CyPB that can crystallize under

conditions similar to those for the crystallization of E coli

CyPA Finally, we succeeded in crystallizing K163T mutant

proteins complexed with a tripeptide,

succinyl-Ala-Pro-Ala-p-nitroanilide (Suc-Ala-Pro-Ala-pNA), and with a

tetrapeptide,

acetyl-Ala-Ala-Pro-Ala-amidomethylcouma-rin (Ac-Ala-Ala-Pro-Ala-AMC), and we found highly

distorted trans-peptides We carried out comparisons of

these complexes with a complex of E coli CyPA and the

tripeptide containing cis-proline, and with a complex of

human CyPA bound to the loop containing the proline in

the trans-form of the capsid protein In addition, we

discussed the importance of the conversion from the sp2- to

sp3-hybrid configuration on the prolyl N atom in the

isomerization of the proline from the trans- to cis-isomer of

unfolded proteins in the refolding process, as well as in the

isomerization of the short peptides containing the proline

from the cis- to trans-isomer

Materials and methods

Preparation of mutantE coli CyPB

The plasmid pATtrpEPPIa, which has a ClaI and a BamHI

site added at the 5¢ and 3¢ ends, respectively, of the gene

encoding amino acid residues 1–190 of E coli CyPB, was

kindly supplied by N Takahashi, Tokyo University of

Agriculture and Technology, Tokyo, Japan [5] PCR was

carried out using a 32-mer primer of 5¢-AAAAAGAAT

TCATCGATATGTTCAAATCGACC-3¢ with EcoRI

added at the 5¢ end of ClaI, a 23-mer primer of 3¢-CGAGA

CGGCATTCCTAGGTTTTT-5¢, and pATtrpEPPIa as a

template The PCR fragment was cleaved with EcoRI and

BamHI, and was subcloned into pUC118, producing an

expression vector, pUCPPIb Mutation was introduced into

pUCPPIb using a QuickChangeTMSite-Directed

Mutagen-esis Kit (Strategene, La Jolla, CA) The codon for Lys187

(AAA) was replaced with ACA (as the purified proteins lose signal sequences of 24 amino acids at the N-terminal, the mutant protein is designated K163T in this paper) The sequences of the mutated DNA were checked using an ABI

373 DNA sequencer (Applied Biosystems) The ClaI-BamHI fragment of each mutant plasmid was replaced with the ClaI-BamHI fragment of pATtrpEPPIa This expression plasmid pATtrpEPPIa (KT) was transformed in

E coli HB101 cells The cells were cultured at 37C in M9CA medium [0.05% (w/v) NaCl, 0.1% (w/v) NH4Cl, 0.2% (w/v) casamino acid, 0.2% (w/v) glucose, 2.0 mM

MgSO4, 0.1 mMCaCl2, 0.6% (w/v) Na2HPO4, 0.3% (w/v)

KH2PO4, pH 7.4] and the proteins were purified as described previously [5]

The PPIase activity was measured using the synthetic peptide Suc-Ala-Ala-Pro-Phe-AMC (Peptide Institute, Inc., Osaka, Japan) The synthetic peptide [a 40 lL solution containing 1.67 mMof peptide, 17% (v/v) dimethylsulfoxide and 35 mMHEPES buffer, pH 7.8] was preincubated with proteins (1.1–4.8 nM) in 2 mL of 35 mM HEPES buffer containing 5 mM 2-mercaptoethanol (pH 7.8), and the assay was started by mechanical mixing with 40 lL of 0.58 mM chymotrypsin in a spectrophotometer cell The fluorescence of AMC from the cleaved trans-peptide [18] was measured at 460 nm using a FP-770 fluorescence spectrophotometer (JASCO Corp., Tokyo, Japan) at 10C

Crystallization, data collection, structure determination and refinement

Whole crystals of K163T mutant proteins were grown by vapor diffusion in hanging drops at 20C A 9 lL drop containing 0.57 mM(12 mgÆmL)1) protein and 6 mM trip-eptide (Suc-Ala-Pro-Ala-pNA (Ptrip-eptide Institute, Inc.), or tetrapeptide (Ac-Ala-Ala-Pro-Ala-AMC (Bachem, Switzer-land), 38–40% (w/v) saturated ammonium, sulfate, 9% (v/v) methanol, 0.04% (w/v) NaN3, and 50 mM Tris/HCl buffer (pH 8.0) was equilibrated against a reservoir solution containing 46% saturated ammonium sulfate, 0.04% (w/v) NaN3, and 100 mM Tris/HCl buffer (pH 8.0) When the peptide dissolved in methanol was added to the drop containing the protein under the above conditions, the solution became turbid, but it became transparent again when left overnight The crystals of the free K163T mutant protein were grown from a drop containing 9.5 mgÆmL)1 protein, 38% (w/v) saturated ammonium sulfate, 0.04% (w/v) NaN3, and 80 mM Tris/HCl buffer (pH 8.0) equilibrated against a reservoir solution of 46% (w/v) saturated ammonium sulfate, 0.04% (w/v) NaN3, and

100 mMTris/HCl buffer (pH 8.0)

Intensity data for crystals were collected using a Weis-senberg camera for macromolecules [19] installed on the beam line BL6A of the Photon Factory (PF) at Tsukuba, Japan Data sets were reduced usingDENZOandSCALEPACK

[20] The structure for the complex of E coli CyPB K163T mutant bound to tripeptide was solved by molecular replacement withXPLOR [21] using E coli CyPA [16] as a search model The model was built usingOsoftware [22], and refinement was assisted by molecular dynamics using

XPLOR The structure of the complex with the tetrapeptide was started from the final structure of the complex with the tripeptide The crystal structure of the free E coli CyPB

Trang 3

K163T was solved by molecular replacement using a model

of the CyPB K163T protein of the complexes, and the final

refinements were made usingCNS[23] The model buildings

on the basis of electron density maps revealed that in all

three kinds of crystals CyPB proteins do not have 24

residues of signal sequence at the N-terminal and were cut

off in the stage of their cultivation or purification After

refinements of the model containing two proteins and water

molecules for two complexes, model building of the peptide

was tried Both of these complexes have an asymmetric unit

containing two CyPB molecules and one peptide The

model of distorted trans-form gave good fitting into the

electron densities in two complexes The final results are

summarized in Table 1

Results

Structure of the K163T mutant ofE coli CyPB

We constructed a mutant that satisfies the following two

conditions Firstly, the mutant residue must not disturb the

folding of the overall skeleton and secondly it must not

affect the binding of peptides containing a proline

A mutant, K163T, in which lysine was replaced by

threonine at residue 163, was selected under these criteria, as

Lys163 is located in b-strand and has no intramolecular

interaction with any residues The kcat/Km value of the

K163T mutant (1.9· 107M )1Æs)1) in the cis- to

trans-isomerization reaction for Suc-Ala-Ala-Pro-Phe-AMC was almost the same as that of the wild-type protein (1.8· 107

M )1Æs)1) Crystals of complexes of mutant K163T CyPB molecules, and tripeptide (Suc-Ala-trans-Pro-Ala-pNA) or tetrapeptide (Ac-Ala-Ala-trans-Pro-Ala-AMC), grew from a solution containing ammonium sulphate under conditions almost identical to those under which crystals of a complex of E coli CyPA and tripeptide (Suc-Ala-cis-Pro-Ala-pNA) grew The crystals of free K163T CyPB also grew from a protein drop containing

no methanol, which was used for dissolving peptides The structural alignments of E coli CyPB, E coli CyPA [16] and human CyPA [6,14] are shown in Fig 1 The CyPB molecules, as well as the E coli and human CyPA molecules, have a b-barrel structure, consisting of upper and lower b-sheets of four antiparallel b-strands enclosed by two a-helices at the top and bottom (Fig 2) In both complexes, CyPB molecule A, i.e the molecule without a peptide, is packed along one 32axis, whereas CyPB molecule B, which

is bound to a peptide, is packed along the other 32axis CyPB molecules A and B exist in a ratio of 1 : 1 in the crystal Molecules A and B, related by a local quasi-twofold rotation axis, make contacts through the side chains of Ile159, Ser161, Thr163 (mutant residue) and Leu165 on the b8 strand, and through Leu8 and Thr10 side chains on the b1 strand In the crystal of free CyPB, a crystallographic twofold rotation axis is observed, and the symmetry of the space group increases from P3, which is found in the

Table 1 Data collection and refinement statistics for E coli CyPB mutant K163T Values in parentheses are for the highest resolution shell.

R merge ¼ S h S i |I h,i ) <I> h |/S h S i I h,i , where <I> h is the mean intensity R factor ¼ S||Fo|-|Fc||/S|Fo| A subset of the data (10%) was excluded from the refinement and used to calculate R free

Peptide Suc-Ala-Pro-Ala-pNA Ac-Ala-Ala-Pro-Ala-AMC none

Data collection

Maximum resolution (A˚) 1.7 (1.76–1.70) 1.8 (1.86–1.80) 1.8 (1.86–1.80)

Completeness (%) 92.0 (73.3) 99.4 (97.5) 99.0 (96.5)

Refinement

Resolution (A˚) 6–1.7 (1.78–1.70) 6–1.8 (1.88–1.80) 8–1.8 (1.82–1.80)

Root-mean-square deviations from ideal values

Average B factors (A˚ 2 )

Trang 4

complexes, to P3221 In the region from 144 to 151 residues

of the molecule in the crystal of free CyPB (Fig 3; shown in

green), the turn structure is broken by the strong interaction

with the adjacent molecule On the other hand, the CyPB

molecules A and B (Fig 3; red and blue, respectively) of the complexes possess the T5 turn of Type II¢ and E coli CyPA molecule has also the similar Type II¢ turn [16]

Short peptides containing atrans-form proline bound

toE coli CyPB

A left-to-right-running cleft is shown in the upper b-sheet of the b3, b4, b6 and b5 strands of the CyPB proteins (Fig 2)

In the center of the cleft (Fig 4), there is a hydrophobic pocket formed by the side chains of Phe53, Met54, Phe112, Leu113 and Tyr122, and by the side chain of Phe104 at the bottom Mainly hydrophilic residues occupy the left half of the cleft, whereas mainly hydrophobic residues occupy the right half The tripeptide Suc-Ala1-Pro2-Ala3-pNA and the tetrapeptide Ac-Ala1-Ala2-Pro3-Ala4-AMC have the distorted trans-form, allowing them to bury deeply into the cleft of CyPB molecules B In the tripeptide, the //w torsional angles of the main chains are)170/100, )56/118 and)86/138 for Ala1, Pro2 and Ala3, respectively In the tetrapeptide these angles are)177/91, )52/122 and )79/ 132 for Ala2, Pro3 and Ala4, respectively The Ala-Pro-Ala segments of the tripeptide and tetrapeptide occupy the exactly same positions (Fig 4), when 166 Ca atoms of CyPB molecules B in the two complexes were superimposed The / and w angles of the Ala residue of Ala-Pro are rarely observed for residues of linear short peptides containing no glycine

The Pro2 and Pro3 residues of the tripeptide and tetrapeptide have an envelope form in which their Cc

Fig 1 Structural alignments of E coli CyPB,

E coli CyPA [16], and human CyPA [6,14].

Pale blue boxes: b-strands; pink: a-helices;

orange: 3 10 helices; and blue: turns Amino

acid residues are shown using a one-letter code

and dots indicate deletions The 14 conserved

residues of the region, in which the peptides

are placed, are written in bold type Asterisks

are shown in 10-residue intervals of E coli

CyPB In E coli CyPB K163T mutant, a Lys

at residue 163 is replaced by a Thr.

Fig 2 The ribbon model of the b-barrel structure of E coli CyPB

consisting of the upper and the lower b-sheets enclosed by two helices.

The colors of ribbon are shown corresponding to those of Fig 1 The

loop colored in green is the region expected to affect the selection of the

substrate Thr163 is located outside of b8 strand The

Suc-Ala-trans-Pro-Ala-pNA is also shown by ball-and-sticks model Figures 2,3,4,5,6

and 7 were prepared using the programs MOLSCRIPT [35] and RASTER 3 D

[36].

Fig 3 Superimposed traces The

superim-posed traces of Ca of CyPB molecule A (red)

without a peptide and CyPB molecule B (blue)

bound by a tripeptide in the complexes, and

CyPB molecule (green) in the crystal of free

CyPB The molecules shown in Figs 2 and 3

are in the same orientation.

Trang 5

atoms lie both above the plane of the coplanar Cb-Ca-N-Cd

as shown in Fig 5 so that their trans-proline rings do not

collide with p electron over the ring of Phe104 at the bottom

of the pocket This envelope form is also observed in

cis-Pro2 of the tripeptide bound to E coli CyPA and in

trans-Pro90 of the loop of the capsid protein bound to

human CyPA but does not belong to any of three

conformations shown in a side-chain rotamer library [24]

The Cc atom of most Pro residues lies down the plane of the

coplanar Cb-Ca-N-Cd as observed in Pro51 (w¼ 141),

Pro71 (w¼ 149), Pro153 (w ¼ 133) and Pro156 (w ¼

137) in the CyPB molecule There is often another envelope

form observed, in which the Cb atom lies down the plane of

the coplanar Ca-N-Cd-Cc as observed in Pro69 (w¼ 176),

Pro72 (w¼ 161) and Pro148 (w ¼)6)

In the tripeptide (tetrapeptide) (Fig 4), CO and NH of

the amide bond of Ala-Pro form no hydrogen bond with the

CyPB molecule, and CO of the amide bond of suc-Ala1

(Ala1-Ala2) forms a hydrogen bond with a distance of

2.77 A˚ (2.59 A˚) to a water molecule, which forms a

hydrogen bond with His47 Ne2with a distance of 2.87 A˚

(2.78 A˚) The carbonyl oxygen atom of Pro2 of the

tripeptide forms a hydrogen bond to the Ng2atom of the

guanidyl group of Arg48 with the distance of 2.62 A˚, and

2.72 A˚ for that of Pro3 of the tetrapeptide Because the w

angles of Pro2 (w¼ 118) of the tripeptide and Pro3 (w ¼

122) of the tetrapeptide deviate from w angles of 130–150

observed for trans-Pro residues, it has became possible to

form a hydrogen bond to the side chain of Arg48 The

aromatic ring of p-nitroanilide in the C-terminal end of the tripeptide overlaps parallel to the ring of Phe112 and the same is observed for that of coumarin of the tetrapeptide Thus the binding of peptides to the cleft of CyPB is mainly due to the hydrophobic interaction

In CyPB molecules B bound to the tripeptide and tetrapeptide (Fig 4), the Arg48 Neatom forms a hydrogen bond to the Gln56 Oe1atom with the distance of 2.85 A˚ for the tripeptide, and 2.94 A˚ for the tetrapeptide The Gln56

Ne2atom forms a hydrogen bond to the Gln102 Oe1atom with the distance of 2.88 A˚ for the tripeptide, and 2.74 A˚ for the tetrapeptide On the other hand, in the CyPB molecules A without peptide and the CyPB molecule in the crystal of free CyPB, the conformations of the side chains of Arg48 differ from those of the CyPB molecules B bound to

a peptide, and no hydrogen bond between Arg48 Neand Gln56 Oe1is formed, whereas these Gln56 Ne2atoms form a hydrogen bond to Gln102 Oe1

Comparison between peptides containingtrans-Pro bound to CyPB and the loop containing Gly-trans-Pro

of the capsid protein bound to human CyPA The crystal structure of the human CyPA complex [6] revealed that the Ala88-Gly89-trans-Pro90-Ile91-Ala92-Pro93-Gly94 region of the most mobile loop in the N-terminal domain of the HIV-1 capsid protein is bound

to the cleft on the upper b-sheet When the cores of E coli CyPB and human CyPA were superimposed, the position of trans-Pro90 of the capsid protein displaces by half of a ring from that of Pro3 of the tetrapeptide as shown in Fig 6 The main chain of the glycine residue immediately preceding Pro90 makes the torsional angles of /¼ 149 and w ¼ 158, which are in the regions in which other amino acids with side chains are disallowed due to steric hindrance The plane of Ca, C and O of Gly89 has the rotation angle x of

 20 from the plane of N, Ca and Cd of Pro90 around the Gly-Pro amide bond The //w torsional angles for Pro90 are )78/141 and the ring of Pro90 is inserted into the hydrophobic pocket Pro90 CO forms hydrogen bonds to Arg55 Ng1and Ng2 atoms with distances of 2.67 A˚ and 2.91 A˚, and the Arg55 Neatom does not form a hydrogen

Fig 4 A stereo view of Suc-Ala-trans-Pro-Ala-pNA (green) and Ac-Ala-Ala-trans-Pro-Ala-AMC (yellow) bound to superimposed E coli CyPB molecules The hydrogen bonds are shown in broken lines The CyPB molecules shown in Figs 4, 6 and 7 were rotated by 45 around the horizontal axis from those shown in Figs 2 and 3.

Fig 5 The model of the envelope form of the proline ring

CO-Ala2-Pro3-Ala4 portion of the tetrapeptide is shown by ball-and-sticks

model.

Trang 6

bond On the other hand, in E coli CyPB molecules B the

side chain of Arg48 is fixed by formation of a hydrogen

bond between the Arg48 Neatom and the Gln56 Oe1atom

and Pro CO of the tripeptide and tetrapeptide forms a

hydrogen bond only to Arg48 Ng2 The difference of the

hydrogen bond formation to the side chain of the Arg

residue of E coli CyPB and human CyPA indicates that

these hydrogen bonds are formed after the Pro residue of

peptides is fixed in the hydrophobic pocket A hydrogen

bond is formed between NH of Ala88 and CO of Gly72 of

human CyPA with a distance of 2.84 A˚ The fixing by

hydrogen bonds of Ala88 and Pro90 to CyPA generates the

deviation of x angle of 20 from the plane around the

Gly-Pro amide bond and the distortion of the torsional

angle of Gly89 This fixing and hydrophobic interaction

agree with the finding that the capsid protein binds rigidly to

human CyPA; even in the presence of a high concentration

of salt or detergent, the binding between them was detected

[25] This is the most mobile loop of the capsid protein, and

it will bind to the human CyPA molecule in conjunction

with a conformational change in the loop The

conforma-tion of acetyl-Ala1 of the tetrapeptide shows a big deviaconforma-tion

from that of His87-Ala88 of the capsid protein

Comparison betweenE coli CyPB with a peptide

of thetrans-proline form and E coli CyPA with a

peptide of thecis-proline form

Crystals were obtained in which

Suc-Ala-trans-Pro-Ala-pNA is bound on E coli CyPB (Fig 7A), whereas crystals

were reported [16] in which Suc-Ala-cis-Pro-Ala-pNA is

bound on E coli CyPA (Fig 7B) In the cis-form of the

tripeptide binding in the cleft of E coli CyPA, torsional

angles //w for Ala1, Pro2 and Ala3 are)119/146, )69/143

and)67/146, respectively The cis-proline ring of Pro2 is

also inserted into the hydrophobic pocket, and CO of Pro2

forms a hydrogen bond with Ng2of the guanidyl group of

Arg43, whereas the succinyl group in the N-terminus

protrudes from the cleft, and NH and CO of Ala1 form

hydrogen bonds with CO and NH of Arg87 The

p-nitro-anilide ring in the C-terminal end lies over the side chain of

the Ile45 residue, parallel with the ring of Phe48

Because all E coli CyPA molecules are bound to the peptide with cis-proline in solution, crystals obtained consist only of complexes On the other hand, in crystals of E coli CyPB analyzed in this study, the CyPB molecule A without peptide and the CyPB molecule B with a peptide exist in the ratio of 1 : 1 The findings that the peptides of the distorted trans-proline form occupy half of the E coli CyPB mole-cules can be attributed to the fact that the binding affinity of peptides of the distorted trans-proline form for CyPB is smaller than that of peptides of the cis-proline form for CyPA Because the concentration of complexes with trans-peptide may be smaller than that of free proteins, crystals consisting of only complexes were not obtained but crystals consisting of the complex and the free protein, the ratio of which is 1 : 1 due to crystal contact, were obtained The fact that crystals of these complexes of E coli CyPB and CyPA grew under the same conditions also indicates that the binding affinity of the trans-form of the tripeptide for CyPB molecule is higher than that for CyPA, whereas the binding affinity of the cis-form is higher for CyPA to the contrary

We were unable to identify any difference of conformation

in 13 of the 14 conserved residues (CyPB/CyPA; His47/42, Arg48/43, Ile50/45, Phe53/48, Met54/49, Gln56/51, Ala91/

86, Arg92/87, Thr100/95, Gln102/97, Phe104/99, Phe112/

107, Leu113/108 and Tyr122/120) of the region in which the tripeptide is placed (Fig 7), whereas the nonsubstantial difference between the CH3-group of Met54 in CyPB and that of Met49 in CyPA reflects only the presence of steric hindrance in the case of the complex of CyPB and the distorted trans-form On the other hand, we found that the different forms of binding peptides are generated due to the difference in areas close to the peptide-binding region, i.e the loop continuing from b5 and the loop connecting the b4 and b5 strands (Figs 2 and 7) Such regions are expected

to determine the orientation of the substrate at the P2 site, i.e the second residue of the N-terminal side from proline in the isomerization reaction of refolding proteins as they proceed from the trans-form to the cis-form The P2 site is responsible for the difference in the rate of the isomerization reaction accelerated by CyPA and CyPB molecules The T4 turns in the loop between the b5 and b6 strands consist of Asp95, Lys96, Asp97 and Ser98 in CyPB and Ala90, Pro91,

Fig 6 Comparison between a loop (His87-Ala88-Gly89-trans-Pro90-Ile91-Ala92-Pro93-Gly94) of the HIV-1 capsid protein bound to human CyPA [6] (PDB code 1AK4) (yellow) and a distorted tetrapeptide Ac-Ala-Ala-trans-Pro-Ala-AMC bound to E coli CyPB (green) The cores of the proteins were superimposed Residues of E coli CyPB and human CyPA are shown in green and yellow with residue numbers (E coli CyPB/human CyPA), respectively.

Trang 7

His92 and Ser93 in CyPA The difference in these side

chains will generate the difference in conformations of the

side chains of Thr93 in CyPB and Thr88 in CyPA The side

chains of Thr93 and Ala94 in CyPB and those of Thr88 and

Gln89 in CyPA will come in contact with the substrate at

the P2 site The part of the loop connecting the b4 and b5

strands, i.e Lys68, Pro69, Asn70 and Pro71 in CyPB and

Ala63, Thr64, Lys65 and Glu66 in CyPA occupies the

bottom left side of the cleft and is close to the

peptide-binding region The difference of hydrophobicity of these

areas between the CyPB and CyPA molecules is expected to

affect the selection of the substrate

Discussion

Short peptides with atrans-proline are distorted

to come to complex with CyPB

CyP proteins accelerate the isomerization reaction from

cis-to trans-form of Suc-Ala-Xaa-cis-Pro-Phe-pNA (Xaa

stands for any amino acid residue) [5,17,18,26–29] and

shorter peptides such as Ala-Pro, Ala-Pro-Phe,

Ala-Ala-Pro-Ala and Ala-Ala-Ala-Ala-Pro-Ala-Ala inhibit cis to trans

isomerase activity of calf thymus CyPA [27] It was

suggested that in the mechanism of the observed

isomeri-zation reaction from cis- to trans-form on CyP proteins, the

N atom of Pro receives a proton from the guanidyl group of

Arg55 on the b3 strand for human CyPA [17] The proton

transfer to the prolyl N atom results in weakening the double bond character of the amide bond of Xaa-Pro The double bond character of this C-N amide bond is due to the hyperconjugation between the p orbital on the sp2 -hybrid type N atom of a proline and the p orbital system

CO of Xaa preceding Pro The N atom of a proline with a proton transferred thereto has an sp3-hybrid rather than

sp2-hybrid orbital; this change in electronic configuration is essential to the transient state of cis to trans isomerization pathway of short peptides catalyzed by CyP proteins As the mutation of Arg to Ala in human CyPA loses the above-mentioned pathway via the proton transfer from the guanidyl group of Arg to the prolyl N atom, the mutant was reported to retain less than 1% of wild type catalytic activity [30] The local energy diagram of the rotating C-N bond of Xaa-Pro for two distinct pathways contributing to cisto trans isomerization of short peptides, which explains the enzymatic activity difference between the wild-type and the mutant, is illustrated in Fig 8A If the isomerization from a cis- to trans-isomer occurs by rotating around the Xaa-Pro amide bond while preserving the planarity of three bonds around the N atom of the Pro residue, the energy barrier DE1for the rotation corresponds to loss of stability

of energy due to the hyperconjugation of the Xaa-Pro amide bond having sp2-hybrid configuration on the N atom On the other hand, if the peptide rotates after the N atom of Pro

in the C-N amide bond of Xaa-Pro accepts a proton to be converted into an sp3-hybrid configuration, the barrier for

Fig 7 The stereo views of clefts of (A) E coli CyPB complexed with Suc-Ala-trans-Pro-Ala-pNA and (B) E coli CyPA complexed with a Suc-Ala-cis-Pro-Ala-pNA [16] (PDB code 1LOP) These were viewed from the same direction using coordination of CyPA superimposed on CyPB The hydrogen bonds are shown in broken lines The conserved residues of the region, in which the tripeptide are placed, are shown in light gray, and the residues, which is expected to affect the selection of the substrate, are shown in green.

Trang 8

the rotation due to only steric hindrance is low (DE2), as sp3

-hybrid configuration on the N atom has no interaction with

CO of Xaa For the reverse conversion from a trans-isomer

having the sp2-hybrid configuration on the N atom of Pro to

a cis-isomer having also the sp2-hybrid configuration, in

addition to DE1, a difference in the energy between these

states, DE3, is also required, and the activation energy for

short peptides is too high for the reverse conversion to

occur

However, in the observed complex of E coli CyPA

with Suc-Ala-cis-Pro-Ala-pNA (Fig 7B), CO of cis-Pro2

forms a hydrogen bond with the distance of 2.75 A˚ to the

Ng2atom of the guanidyl group of the Arg43 on the b3

strand, but the N atom of Pro2 is 4.02 A˚ away from the

Ng2atom of Arg43 The Ng1atom of Arg43 is not within

5.5 A˚ from the N atom of Pro2 In addition, NH and CO

of Ala1 of the cis-form have hydrogen bonds with the CO

and NH of Arg87, respectively The amide bond of

Ala-cis-Pro is planar and the N atom of Pro has the

sp2-hybrid configuration

In E coli CyPB molecules B bound to Suc-Ala-trans-Pro-Ala-pNA and Ac-Ala-Ala-trans-Pro-Ala-AMC (Figs 4 and 7A), the Ng2atom of Arg48 forms a hydrogen bond with the distance of 2.62 A˚ and 2.72 A˚ to CO of trans-Pro of the tripeptide and tetrapeptide, respectively In these complexes, the distance of the N atom of Pro and the Ng2 atom of Arg48 is 3.08 A˚ and 3.02 A˚, and the angle between the Ng2

-N vector and normal vector to the amide bond plane of Ala-Pro is 16 and 17, respectively The Ng1atom of Arg48 is not within 5.0 A˚ from the N atom of Pro For both peptides, the amide bond of Ala-trans-Pro is planar and the

N atom of Pro has an sp2-hybrid configuration

In conclusion, the proton transfer from the guanidyl group of Arg to the prolyl N atom no longer occurs in the complex of E coli CyPA, as hydrogen bonding to

CO of Ala1 gives rise to the increased double bond character of the Ala1-Pro2 amide bond and the guanidyl group of Arg43 is far from the N atom of Pro2 In the case of the observed complex of CyPB, because the hydrogen bond between the guanidyl group of Arg48 and CO of Pro plays an essential role in the binding of the peptide, it is impossible for the guanidyl group of Arg48 to be involved in proton transfer to the prolyl N atom These facts show that in both cases the enzyme cannot carry out the isomerization of these peptides observed in crystals of complexes Similarly, a crystal structure [15] of the tetrapeptide Ac-Ala-Ala-cis-Pro-Phe-pNA staying in unreacted form on human CyPA also demonstrated that Arg55 forms a hydrogen bond with the CO of cis-Pro of the tetrapeptide, and that this peptide retains still planarity of the Ala-cis-Pro amide bond

In the case of CyPB in complexes with Suc-Ala-trans-Pro-Ala-pNA and Ac-Ala-Ala-trans-Pro-Ala-AMC, the large distortion in the orientation of Ala1 and Ala2 of Ala-Pro with //w torsional angles of )170/100 and )177/91 allows the fixing of CO of Suc and Ala1 to His47 Ne2via a mediating water molecule The fixing to Arg48 and His47 makes a major contribution to binding of peptides in the trans-form In contrast, as for CyPA in complex with Suc-Ala-cis-Pro-Ala-pNA, two hydrogen bonds of NH and CO

of Ala1 are formed, and the orientation of Ala1 has a little distortion

When CO of Xaa preceding Pro has no formation of a hydrogen bond, the double bond character of this C-N amide bond is due only to the hyperconjugation Proton transfer to the prolyl N atom results in weakening the double bond character of the amide bond of Xaa-Pro As result, the N atom of a proline with a proton transferred thereto has an sp3-hybrid rather than an sp2-hybrid orbital, and thus the planar configuration of the N atom of proline

is converted to an ammonium type configuration As the contribution of the hyperconjugation into the stability by

sp2-hybrid orbital on the N atom of Pro is lost owing to the small rotation around the amide bond of Xaa-Pro, the process for the conversion from sp2- to sp3-hybrid confi-guration is enhanced

The above mentioned mechanism for short peptides, where the conversion from sp2- to sp3-hybrid configuration has a critical contribution to in vitro cis to trans peptidyl-prolyl isomerization activity of CyP proteins, may be extended to understand the in vitro trans to cis

peptidyl-Fig 8 The local energy diagram of the rotating C-N bond of Xaa-Pro.

(A) Two distinct pathways contributing to cis to trans isomerization of

short peptides (B) Two distinct pathways contributing to trans to cis

isomerization of unfolded proteins, which possess the cis-proline

conformation in the natural folding state.

Trang 9

prolyl isomerization involved in the reported enhancement

by CyP proteins in the refolding process of unfolded

proteins (e.g RNase A, carbonic anhydrase II, and

RNase T1 proteins [7–11]), which possess a cis-proline

conformation in the natural folding state In the in vitro

refolding experiment without CyP proteins, the in vitro trans

to cis peptidyl-prolyl isomerization was observed to progress

slowly, which may be attributed to such a direct path

requiring larger activation energy DE5 where the

trans-isomer with the sp2-hybrid configuration on the N atom of

Pro is directly isomerized to the cis-isomer with the sp2

-hybrid configuration (Fig 8B) On the other hand, in the

in vitrosystem with CyP proteins, the in vitro trans to cis

peptidyl-prolyl isomerization was enhanced remarkably,

which may be reasonably understood to be due to such an

indirect path requiring a smaller activation energy DE4 The

conversion from the sp2- to the sp3-hybrid configuration on

the N atom of Pro of the trans-isomer is enzymatically

conducted by means of CyP proteins, being followed by the

quick isomerization from the trans-isomer with the sp3

-hybrid configuration to the cis-isomer with the sp3-hybrid

configuration At the stage of the enzymatic conversion

from the sp2- to the sp3-hybrid configuration on the N atom

of Pro of the trans-isomer, the guanidyl group of Arg should

be used only for the proton transfer to the N atom of Pro

rather than the hydrogen-bonding to the CO of Pro so that

the guanidyl group of Arg may be positioned much closer to

the N atom of Pro than that observed in CyPB in complex

with Suc-Ala-trans-Pro-Ala-pNA or

Ac-Ala-Ala-trans-Pro-Ala-AMC analyzed here Thus, in place of hydrogen

bonding of the guanidyl group of Arg to CO of Pro,

another amino acid residue located somewhat behind the

Pro concerned is predicted to be involved in the binding of

unfolded proteins to CyP proteins In such a predicted

binding form, the proline containing the peptide portion of

the unfolded proteins embedded in the cleft of CyP proteins

may have not only the distortion of Xaa of Xaa-Pro but also

additional distortion in the C-terminal region next to the

Pro These distortions may be effectively used as driving

force for quick isomerization from the trans-isomer with the

sp3-hybrid configuration to the cis-isomer with the sp3

-hybrid configuration in the enhanced refolding process of

unfolded proteins observed in the the in vitro system with

CyP proteins

It has been reported that strains of the yeast

Saccharo-myces cerevisiae in which all eight identified CyP family

genes were disrupted survived [31–33] Therefore, CyPs

appear to be irrelevant to the in vivo folding process for

native proteins that possess a cis-proline conformation As

explained above, CyPA and CyPB may have an

advanta-geous potential for binding distorted peptide portions of

partially unfolded proteins in its cleft If such a distorted

peptide portion of a partially unfolded protein resulting

from extrinsic causes (for example, heat shock) is bound in

the cleft of CyPA or CyPB protein, further progress of the

protein denaturation induced by the extrinsic causes would

be successfully blocked In such a case, when the extrinsic

cause is removed from the partially unfolded proteins held

in the CyPA or CyPB protein, successful refolding of this is

achieved to make a quick recovery from damage due to the

extrinsic causes Such a possible function of CyPs to block

the extensive denaturing course of proteins promoted by

extrinsic causes may provide a more probable explanation for previous reports [34] that yeast strains lacking CyPA and CyPB are sensitive to heat shock, and that both of these proteins facilitate the survival of cells exposed to high temperatures

Protein Data Bank access codes Coordinates of the structures have been deposited in the Protein Data Bank (accession codes 1V9T and 1VAI for the two kinds of complexes of the E coli CyPB K163T mutant bound by Suc-Ala-trans-Pro-Ala-pNA and Ac-Ala-Ala-trans-Pro-Ala-AMC, and accession code 1J2A for the

E coliCyPB K163T mutant)

Acknowledgements

We thank Dr Mamoru Suzuki and Dr Noriyoshi Sakabe at the High Energy Accelerator Research Organization, KEK, for their help in the data collection This work was supported in part by a grant from the National Project on Protein Structural and Functional Analyses

to M K.

References

1 Harding, M.W., Handschumacher, R.E & Speicher, D.W (1986) Isolation and amino acid sequence of cyclophilin J Biol Chem.

261, 8547–8555.

2 Galat, A (1993) Peptidylproline cis-trans-isomerases: immuno-philins Eur J Biochem 216, 689–707.

3 Hunter, T (1998) Prolyl isomerases and nuclear function Cell 92, 141–143.

4 Liu, J & Walsh, C.T (1990) Peptidyl-prolyl cis-trans-isomerase from Escherichia coli: a periplasmic homolog of cyclophilin that is not inhibited by cyclosporin A Proc Natl Acad Sci USA 87, 4028–4032.

5 Hayano, T., Takahashi, N., Kato, S., Maki, N & Suzuki, M (1991) Two distinct forms of peptidylprolyl-cis-tarns-isomerase are expressed separately in periplasmic and cytoplasmic compart-ments of Escherichia coli cells Biochem 30, 3041–3048.

6 Gamble, T.R., Vajdos, F.F., Yoo, S., Worthylake, D.K., Hous-eweart, M., Sundquist, W.I & Hill, C.P (1996) Crystal structure

of human cyclophilin A bound to the amino-terminal domain of HIV-1 capsid Cell 87, 1285–1294.

7 Lang, K., Schmid, F.X & Fischer, G (1987) Catalysis of protein folding by prolyl isomerase Nature 329, 268–270.

8 Scho¨nbrunner, E.R., Mayer, S., Tropschug, M., Fischer, G., Takahashi, N & Schmid, F.X (1991) Catalysis of protein folding

by cyclophilins from different species J Biol Chem 266, 3630–3635.

9 Freskga˚rd, P.-O., Bergenhem, N., Jonsson, B.-H., Svensson, M & Carlsson, U (1992) Isomerase and chaperone activity of prolyl isomerase in the folding of carbonic anhydrase Science 258, 466–468.

10 Fransson, C., Freskga˚rd, P.-O., Herbertsson, H., Johansson, A˚., Jonasson, P., Ma˚rtensson, L.-G., Svensson, M., Jonsson, B.-H & Carlsson, U (1992) Cis-trans isomerization is rate-determining in the reactivation of denatured human carbonic anhydrase II as evidenced by proline isomerase FEBS Lett 296, 90–94.

11 Schmid, F.X (1993) Prolyl isomerase: Enzymatic catalysis of slow protein-folding reactions Annu Rev Biophys Biomol Struct 22, 123–143.

12 Kallen, J., Spitzfaden, C., Zurini, M.G.M., Wider, G., Widmer, H., Wu¨thrich, K & Walkinshaw, M.D (1991) Structure of

Trang 10

human cyclophilin and its binding site for cyclosporin A

determined by X-ray crystallography and NMR spectroscopy.

Nature 353, 276–279.

13 Kallen, J & Walkinshaw, M.D (1992) The X-ray structure of a

tetrapeptide bound to the active site of human cyclophilin A.

FEBS Lett 300, 286–290.

14 Ke, H., Mayrose, D & Cao, W (1993) Crystal structure of

cyclophilin A complexed with substrate Ala-Pro suggests a

solvent-assisted mechanism of cis-trans isomerization Proc Natl

Acad Sci USA 90, 3324–3328.

15 Zhao, Y & Ke, H (1996) Crystal structure implies that cyclophilin

predominantly catalyzes the trans to cis isomerization Biochem.

35, 7356–7361.

16 Konno, M., Ito, M., Hayano, T & Takahashi, N (1996) The

substrate-binding site in Escherichia coli cyclophilin A preferably

recognizes a cis-proline isomer or highly distorted form of the trans

isomer J Mol Biol 256, 897–908.

17 Eisenmesser, E.Z., Bosco, D.A., Akke, M & Kern, D (2002)

Enzyme dynamics during catalysis Science 295, 1520–1523.

18 Fischer, G., Bang, H & Mech, C (1984) Determination of

enzymatic catalysis for the cis-trans-isomerization of peptide

binding in proline-containing peptides Biomed Biochim Acta 43,

1101–1111.

19 Sakabe, N (1991) X-ray diffraction data collection system for

modern protein crystallography with a Weissenberg camera and

an imaging plate using synchrontron radiation Nucl Instrum.

Methods Phys Res A 303, 448–463.

20 Otwinowski, V & Minor, W (1997) Processing X-ray diffraction

data collected in oscillation mode Methods Enzymol 276, 307–

326.

21 Bru¨nger, A.T (1993) X-PLOR, Version 3.1: a System for

X-ray crystallography and NMR Yale University Press,

New Haven, CT.

22 Jones, T.A (1978) A graphics model building and refinement

system for macromolecules J Appl Crystallogr 11, 268–272.

23 Bru¨nger, A.T., Adams, P.D., Clore, G.M., DeLano, W.L., Gros,

P., Grosse-Kunstleve, R.W., Jiang, J.-S., Kuszewski, J., Nilges,

M., Pannu, N.S., Read, R.J., Rice, L.M., Simonson, T & Warren,

G.L (1998) Crystallography & NMR system: a new software suite

for macromolecular structure determination Acta Crystallogr D

54, 905–921.

24 Ponder, J.W & Richards, F.M (1987) Tertiary templates for

proteins J Mol Biol 193, 775–791.

25 Luban, J., Bossolt, K.L., Franke, E.K., Kalpana, G.V & Goff, S.P (1993) Human immunodeficiency virus type 1 gag protein binds to cyclophilins A and B Cell 73, 1067–1078.

26 Liu, J., Albers, M.W., Chen, C., Schreiber, S.L & Walsh, C.T (1990) Cloning, expression, and purification of human cyclophilin

in Escherichia coli and assessment of the catalytic role of cysteines

by site-directed mutagenesis Proc Natl Acad Sci USA 87, 2304– 2308.

27 Harrison, R.K & Stein, R.L (1990) Mechanistic studies of pep-tidyl prolyl cis-trans isomerase: Evidence for catalysis by distor-tion Biochem 29, 1684–1689.

28 Kofron, J.L., Kuzmie`, P., Kishore, V., Colo´n-Bonilla, E & Rich, D.H (1991) Determination of kinetic constants for peptidyl prolyl cis-trans isomerases by an improved spectrophotometric assay Biochem 30, 6127–6134.

29 Kakalis, L.T & Armitage, I.M (1994) Solution conformation of a cyclophilin-bound proline isomerase substrate Biochem 33, 1495– 1501.

30 Zydowsky, L.D., Etzkorn, F.A., Chang, H.Y., Ferguson, S.B., Stolz, L.A., Ho, S.I & Walsh, C.T (1992) Active site mutants of human cyclophilin A separate peptidyl-prolyl isomerase activity from cyclosporin A binding and calcineurin inhibition Protein Sci 1, 1092–1099.

31 Haendler, B., Keller, R., Hiestand, P.C., Kocher, H.P., Wegmann, G & Movva, N.R (1989) Yeast cyclophilin: isola-tion and characterizaisola-tion for the protein, cDNA and gene Gene

83, 39–46.

32 Tropschung, M., Barthelmess, I.B & Neupert, W (1989) Sensivity

to cyclophilin A is mediated by cyclophilin in Neurospora crassa and Saccharomyces cerevisiae Nature 342, 953–955.

33 Dolinski, K., Muir, S., Cardenas, M & Heitman, J (1997) All cyclophilins and FK506 binding proteins are, individually and collectively, dispensable for viability in Saccharomyces cerevisiae Proc Natl Acad Sci USA 94, 13093–13098.

34 Sykes, K., Gething, M.-J & Sambrook, J (1993) Proline iso-merases function during heat shock Proc Natl Acad Sci USA 90, 5853–5857.

35 Kraulis, P.J (1991) MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures J Appl Crys-tallogr 24, 946–950.

36 Mettitt, E.A & Murphy, E.P (1994) Raster 3d, Version 2.0 A program for photorealistic molecular graphics Acta Crystallogr.

D 50, 869–873.

Ngày đăng: 30/03/2014, 15:20

TỪ KHÓA LIÊN QUAN

TÀI LIỆU CÙNG NGƯỜI DÙNG

TÀI LIỆU LIÊN QUAN

🧩 Sản phẩm bạn có thể quan tâm